May 28, 2026 07:00AM
Apr 29, 2026 07:42AM
Apr 29, 2026 07:42AM
Mar 30, 2026 07:01AM
Mar 30, 2026 07:00AM
Mar 25, 2026 08:28AM
Mar 25, 2026 07:01AM KalVista reports $49.1 million EKTERLY revenue in eight-month period
Mar 25, 2026 07:00AM
Mar 18, 2026 07:00AM
Mar 2, 2026 07:01AM
Mar 2, 2026 07:00AM
Feb 18, 2026 07:00AM
Feb 18, 2026 07:00AM
Feb 12, 2026 07:00AM KalVista Pharmaceuticals to Present EKTERLY® (sebetralstat) Data at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting
Jan 8, 2026 04:07PM
Jan 8, 2026 04:05PM
Dec 22, 2025 06:00AM
Dec 22, 2025 06:00AM
Nov 11, 2025 12:44AM
Nov 10, 2025 04:30PM
Nov 6, 2025 08:02AM KalVista presents patient satisfaction data for EKTERLY at ACAAI meeting
Nov 6, 2025 08:01AM
Nov 3, 2025 07:00AM
Oct 30, 2025 07:00AM
Oct 6, 2025 04:00PM
Oct 6, 2025 04:00PM
Oct 6, 2025 07:00AM
Oct 6, 2025 07:00AM KalVista Pharmaceuticals Appoints Bilal Arif as Chief Operating Officer and Linea Aspesi as Chief People Officer
Oct 2, 2025 07:00AM
Oct 2, 2025 07:00AM
Sep 26, 2025 07:00AM
Sep 24, 2025 10:52PM
Sep 24, 2025 10:52PM
Sep 24, 2025 04:01PM
Sep 24, 2025 04:01PM KalVista Pharmaceuticals Announces Proposed Offering of $110.0 Million of Convertible Senior Notes
Sep 19, 2025 07:00AM
Sep 19, 2025 07:00AM
Sep 12, 2025 04:06AM
Sep 11, 2025 07:04AM
Sep 11, 2025 07:02AM
Sep 11, 2025 07:00AM
Sep 4, 2025 07:05AM KalVista Pharmaceuticals to Provide Operational Update and Fiscal Quarter Financial Results on September 11, 2025
Aug 11, 2025 07:00AM
Jul 25, 2025 08:00AM
Jul 25, 2025 08:00AM
Jul 15, 2025 04:05PM
Jul 15, 2025 04:05PM
Jul 10, 2025 10:29AM
Jul 10, 2025 07:00AM KalVista Pharmaceuticals Provides Operational Update and Fiscal Year 2025 Financial Results
Jul 7, 2025 06:31AM

1,197,272 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All